RBC Capital Maintains Outperform on Insulet, Lowers Price Target to $280
Insulet Corporation
Insulet Corporation PODD | 0.00 |
RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:
PODD) with a Outperform and lowers the price target from $325 to $280.
